Global Hypercoagulable Treatment Market, By Type (Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, and Others),  Drugs (Heparin, Warfarin, Vitamin K Antagonist, Direct Thrombin Inhibitors and Others),  Route of Administration (Oral and Injectable),  End-Users (Hospitals, homecare, Speciality Centres, and Others),  Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others),  Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028